G protein gamma 7 expression as a new clinicopathological marker in patients with intrahepatic cholangiocarcinoma - PubMed (original) (raw)
G protein gamma 7 expression as a new clinicopathological marker in patients with intrahepatic cholangiocarcinoma
Tohru Utsunomiya et al. Arch Surg. 2002 Feb.
Abstract
Hypothesis: The signal alterations mediated by small G proteins such as Ras, Rho, and Rac have been reported in several cancers. The human G protein gamma 7 (G-gamma 7) gene, which is down-regulated in various digestive organ cancers, was recently identified and cloned. Thus, the G-gamma 7-coupled heterotrimeric G proteins may also contribute to carcinogenesis in human cancers.
Setting: University hospital and medical institute of bioregulation.
Patients and methods: The clinicopathological significance of G-gamma 7 expression in 18 patients with intrahepatic cholangiocarcinoma (IHCC) was examined. The tumor-nontumor ratio of G-gamma 7 expression was determined using reverse transcription polymerase chain reaction analysis. To visualize the localization of G-gamma 7, an immunohistochemical study was performed.
Main outcome measure: Clinicopathological significance of G-gamma 7 expression in human IHCC.
Results: Expression of G-gamma 7 messenger RNA was lower in tumor tissue than in the corresponding nontumor tissue in 17 (94%) of 18 patients with IHCC. The mean tumor-nontumor ratio was 0.54. Eleven patients with tumor-nontumor ratios less than 0.5 showed significantly poorer differentiated IHCC than 7 with tumor-nontumor ratios of 0.5 and greater (P<.01). Decreased expression of G-gamma 7 protein in the carcinoma tissue, especially in the poorly differentiated IHCC tissue, was confirmed using immunohistochemical staining.
Conclusions: Reduced expression of G-gamma 7 is associated with the histological grade of IHCC and may therefore prove to be a useful marker for predicting the biological aggressiveness of human IHCC.
Similar articles
- Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
Wang M, Gong B, Li Y, Wang Y. Wang M, et al. Hematol Oncol Stem Cell Ther. 2010;3(2):66-70. doi: 10.1016/s1658-3876(10)50037-2. Hematol Oncol Stem Cell Ther. 2010. PMID: 20543539 - Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Yang SZ, Wang AQ, Du J, Wang JT, Yu WW, Liu Q, Wu YF, Chen SG. Yang SZ, et al. World J Gastroenterol. 2016 Jul 7;22(25):5814-21. doi: 10.3748/wjg.v22.i25.5814. World J Gastroenterol. 2016. PMID: 27433094 Free PMC article. - Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.
Zhang KJ, Zhang BY, Zhang KP, Tang LM, Liu SS, Zhu DM, Zhang DL. Zhang KJ, et al. World J Gastroenterol. 2010 May 28;16(20):2554-7. doi: 10.3748/wjg.v16.i20.2554. World J Gastroenterol. 2010. PMID: 20503457 Free PMC article. - Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M. Iguchi T, et al. Hum Pathol. 2009 Feb;40(2):174-80. doi: 10.1016/j.humpath.2008.06.029. Epub 2008 Oct 5. Hum Pathol. 2009. PMID: 18835624 - High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF, Ge FJ, Han B, Yang XQ, Su H, Zhao AC, Zhao MH, Yang YB, Yang J. Xu YF, et al. World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256. World J Gastroenterol. 2015. PMID: 25805932 Free PMC article.
Cited by
- Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer.
Ohta M, Mimori K, Fukuyoshi Y, Kita Y, Motoyama K, Yamashita K, Ishii H, Inoue H, Mori M. Ohta M, et al. Br J Cancer. 2008 Jan 29;98(2):410-7. doi: 10.1038/sj.bjc.6604124. Epub 2008 Jan 22. Br J Cancer. 2008. PMID: 18219292 Free PMC article. - Subtype-dependent regulation of Gβγ signalling.
Tennakoon M, Senarath K, Kankanamge D, Ratnayake K, Wijayaratna D, Olupothage K, Ubeysinghe S, Martins-Cannavino K, Hébert TE, Karunarathne A. Tennakoon M, et al. Cell Signal. 2021 Jun;82:109947. doi: 10.1016/j.cellsig.2021.109947. Epub 2021 Feb 11. Cell Signal. 2021. PMID: 33582184 Free PMC article. Review. - Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments.
Duan H, Chen B, Wang W, Luo H. Duan H, et al. Aging (Albany NY). 2023 Feb 24;15(5):1445-1474. doi: 10.18632/aging.204545. Epub 2023 Feb 24. Aging (Albany NY). 2023. PMID: 36863706 Free PMC article. - Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Lai CH, Liang XZ, Liang XY, Ma SJ, Li JG, Shi MF, Zhu X, Lan HH, Zeng JH. Lai CH, et al. Biomed Res Int. 2019 Oct 15;2019:8016120. doi: 10.1155/2019/8016120. eCollection 2019. Biomed Res Int. 2019. PMID: 31737678 Free PMC article. - Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.
Sudo T, Utsunomiya T, Mimori K, Nagahara H, Ogawa K, Inoue H, Wakiyama S, Fujita H, Shirouzu K, Mori M. Sudo T, et al. Br J Cancer. 2005 May 9;92(9):1754-8. doi: 10.1038/sj.bjc.6602531. Br J Cancer. 2005. PMID: 15856046 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous